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Prior to parturition the non-pliable uterine cervix undergoes a ripening process (“softens” and dilates) to allow a 
timely passage of the fetus at term. The exact mechanism(s) triggering and involved in cervical ripening are unknown, 
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changes biosynthesis and release over pregnancy, that estrogen, acting via the ER pathway, increases synthesis of SP in 
DRG, and that SP is utilized in cervical ripening at late pregnancy. Using immunohistochemistry, in situ hybridization, 
reverse transcriptase–polymerase chain reaction (RT–PCR) and radioimmunoassay (RIA), we investigated 
coexpression of ER-G/13 and SP; differential expression of ER-G and -13 mRNA in DRG neurons; SP synthesis in 
DRG; and changes in SP concentration in the cervix, DRG and spinal cord over pregnancy. In addition, the effect of 
exogenous estrogen on SP synthesis in L6-S1 DRG of ovariectomized rats was examined. SP-immunoreactive neurons 
expressed ER-G and ER-13. SP synthesis (expressed as 13-PPT mRNA label) was prominent in small DRG neurons. SP 
concentration increased in the L6-S1 DRG and spinal cord segments, with a peak at Day 20 of gestation, but decreased 
in the cervix during the first two trimesters, with a rise over the last trimester to Day 10 levels. SP and ER-G mRNA 
synthesis increased in DRG over pregnancy but ER-13 mRNA levels were largely unchanged. When ovariectomized 
rats were treated with exogenous estrogen, SP mRNA synthesis in the DRG increased in a dose-related manner, an 
effect blocked by ER blocker ICI 182 780. From these results, we postulate that synthesis of SP in L6-S1 DRG and 
utilization in the cervix increase over pregnancy and this synthesis is under influence of the estrogen–ER system, most 
likely ER-G. We postulate that SP may play a role in cervical ripening and, consequently in the birth process.
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Abstract 
Prior to parturition the non-pliable uterine cervix undergoes a ripening process (“softens” and dilates) to allow a timely passage of the 
fetus at term. The exact mechanism(s) triggering and involved in cervical ripening are unknown, though evidence for a role for sensory 
neurons and their contained neuropeptides is emerging. Moreover, an apparent increase in neuropeptide immunoreactive nerves occurs 
in the cervix during pregnancy, maternal serum estrogen levels rise at term and uterine cervix-related L6-S1 dorsal root ganglia (DRG) 
sensory neurons express estrogen receptor (ER) and neuropeptides. Thus, we sought to test the hypothesis that the neuropeptide substance P 
(SP) changes biosynthesis and release over pregnancy, that estrogen, acting via the ER pathway, increases synthesis of SP in DRG, and that 
SP is utilized in cervical ripening at late pregnancy. Using immunohistochemistry, in situ hybridization, reverse transcriptase–polymerase 
chain reaction (RT–PCR) and radioimmunoassay (RIA), we investigated coexpression of ER-G/13 and SP; differential expression of ER-G 
and -13 mRNA in DRG neurons; SP synthesis in DRG; and changes in SP concentration in the cervix, DRG and spinal cord over pregnancy. 
In addition, the effect of exogenous estrogen on SP synthesis in L6-S1 DRG of ovariectomized rats was examined. SP-immunoreactive 
neurons expressed ER-G and ER-13. SP synthesis (expressed as 13-PPT mRNA label) was prominent in small DRG neurons. SP concentration 
increased in the L6-S1 DRG and spinal cord segments, with a peak at Day 20 of gestation, but decreased in the cervix during the first two 
trimesters, with a rise over the last trimester to Day 10 levels. SP and ER-G mRNA synthesis increased in DRG over pregnancy but ER-13 
mRNA levels were largely unchanged. When ovariectomized rats were treated with exogenous estrogen, SP mRNA synthesis in the DRG 
increased in a dose-related manner, an effect blocked by ER blocker ICI 182 780. From these results, we postulate that synthesis of SP in 
L6-S1 DRG and utilization in the cervix increase over pregnancy and this synthesis is under influence of the estrogen–ER system, most 
likely ER-G. We postulate that SP may play a role in cervical ripening and, consequently in the birth process. 
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1. Introduction
During pregnancy the quiescent uterus provides a favor- 
able environment for the growing fetus and the non-pliable 
cervix acts as a sphincter to keep the fetus in utero. How- 
ever, at term the cervix undergoes tissue remodeling leading 
to softening and dilatation (‘ripens’), whereas the uterus 
contracts to facilitate passage of the fetus. Failure of either 
or both of these events leads to birthing problems such as 
preterm birth or protracted labor [13]. 
Cervical ripening is a complex process that is regulated 
by numerous factors, many of which have been studied 
extensively such as nitric oxide, cytokines, prostaglandins, 
relaxin and steroids hormones [1,18,51,83]. However, the 
exact mechanism(s) triggering cervical ripening remain 
elusive. Moreover, changes in the cervix at ripening are 
similar to those seen in inflammatory reactions, especially 
neurogenic inflammation [16,42], suggesting that nerves 
play an important role in cervical ripening. However, even 
though it is known that the cervix is richly innervated with 
autonomic and sensory nerves [4,57–59,85] and that tran- 
section of the sensory nerves blocks labor [10,27], the role 
of uterine cervix-related nerves is poorly understood. 
Our laboratory has established the fundamental anatomic 
organization essential for neurogenic inflammation in the 
cervix of parturient rats, which we believe may play a cru- 
cial role in cervical ripening [16]. Uterine cervical afferent 
nerves, containing inflammation-associated neuropeptides, 
including substance P (SP), are closely associated with leaky 
 
 
venules and smooth muscle cells in the cervix of parturient 
rats [16]. Interestingly, administration of SP to ovariec- 
tomized rats mimics aspects of neurogenic inflammation 
observed in the parturient cervix, i.e. immune cell recruit- 
ment,  vasodilation  and  plasma  extravasation,  suggesting 
that SP may play an important role in cervical ripening [16]. 
SP is a member of the tachykinin family of peptide neu- 
rotransmitters, namely SP, neurokinin A (NKA) and neu- 
rokinin B (NKB), that are derived from preprotachykinin 
(PPT) gene by alternative splicing [12,53]. Moreover, three 
distinct G protein-coupled cell membrane receptors, NK1, 
2 and 3, are activated preferentially by SP, NKA and NKB, 
respectively [49,70]. SP is found in sensory nerves inner- 
vating peripheral tissues [28,55,71,72] including the uterine 
cervix [16,57,59,79] and, when locally released, causes pain 
and neurogenic inflammation [21,29]. In addition, NK1 re- 
ceptor immunoreactivity is associated with target tissues in 
the cervix and its synthesis increases over pregnancy [16]. 
However, to date studies are not available on the effects of 
changing estrogen levels in the cervix over pregnancy, its in- 
fluence on neurotransmitters and their potential involvement 
in cervical ripening. 
Several studies have established that (i) maternal serum 
estrogen levels rise over pregnancy peaking near term 
[8,46,76], (ii) dorsal root ganglion (DRG) neurons express 
estrogen receptor (ER) [63,64,82] including those in the 
L6-S1 segmental DRG that innervate the uterus [60,65,67], 
(iii) some ER containing DRG neurons express SP [60,61], 
and (iii) SP is transported to the pelvic organs (cervix in- 
cluded) from L6-S1 DRG [48,67]. On the basis of these 
data, we hypothesize that rising estrogen levels at term 
could stimulate, via ER, an increased synthesis of SP. The 
neuropeptide is then transported to sensory nerve terminals 
in the cervix for release and binding to NK1 receptors to 
participate in remodeling of the cervix. 
To test this hypothesis, the present study utilized immuno- 
histochemistry, in situ hybridization, RT–PCR and radioim- 
munoassay (RIA) to investigate coexpression of ER and SP 
in DRG neurons, SP synthesis in DRG, and changes in SP 
concentration in the cervix, DRG and spinal cord over preg- 
nancy. The effect of exogenous estrogen on SP synthesis 
was investigated in ovariectomized rats. 
 
 
2. Materials and methods 
 
2.1. Animals 
 
Adult female Sprague–Dawley rats (SASCO strain from 
Charles Rivers) were used in these studies. Nonpregnant and 
timed-pregnant rat at gestational days 10, 15, 20, parturient 
(Day 22) and 2-day postpartum were included in the studies. 
A total number of 90 pregnant animals [n = 5 (radioim- 
munoassay, immunohistochemistry and in situ hybridiza- 
tion) and n = 3 (RT–PCR) representative time points] and 
18 nonpregnant animals [n = 3 for each type of treatment 
(1713-estradiol and ER blocker, ICI 182 780) were used]. All 
experiments were performed in accordance with the NIH 
Guide for the Care and Use of Laboratory Animals (NIH 
Publications No. 86-23) revised 1985. During all experi- 
ments efforts were made to minimize both animal suffering 
and numbers of animals used. 
 
2.2. Radioimmunoassay 
 
Pregnant rats were euthanized with sodium pentobarbital 
(100 mg/kg body weight, i.p.), and perfused intra-cardially 
only with 0.9% sodium chloride. The cervix, L6-S1 DRG 
and spinal cord segments (dorsal one-half only) were care- 
fully removed and stored frozen at −80 ◦C until processing. 
Frozen samples were homogenized and extracted in 2 N 
acetic acid. An aliquot of the homogenate was used for 
protein determination (Bio-Rad). After centrifugation, the 
supernatants were lyophilized and used for RIA. SP was 
determined using  antiserum RD2  (gift of  Dr.  S.E. Lee- 
man), [125I] Bolton-Hunter-SP (Amersham) as radioligand 
and synthetic SP (Sigma Chemical Co., St. Louis, MO) as 
standard [40]. 
 
2.3. Immunohistochemistry 
 
For immunohistochemical studies  of  the  expression 
of ER and SP in DRG neurons, nonpregnant rats were 
ovariectomized. Animals were anesthetized with sodium 
pentobarbital (45 mg/kg, i.p.) and ovariectomized via two 
small dorsal incisions. Incisions were closed with a single 
stitch to the muscle layer and a single wound clip to the 
skin. After 7–10 days survival the rats were deeply anes- 
thetized (100 mg/kg sodium pentobarbital, i.p.) and exsan- 
guinated by cardiac perfusion with saline followed by 4% 
para-formaldehyde in 0.1 M phosphate buffer, pH 7.3. The 
L6-S1 DRG were removed, cryoprotected in 30% sucrose, 
frozen, and sectioned (14 µm thick) on a cryostat. Sections 
were processed on slide for immunohistochemistry to local- 
ize SP and ER-G or ER-13 by standard techniques routinely 
used in our laboratory [58,60–63]. Briefly, sections of DRG 
were incubated for 16–24 h at room temperature with a 
cocktail of primary antibodies: (i) a guinea pig generated an- 
tibody against SP (dilution 1:800; gift of Dr. Catia Sternini, 
CURE at UCLA, Los Angeles, CA) and a rabbit generated 
antibody against ER-G (1:2500 dilution; code 1355; gift 
of Dr. Margaret Shupnik, University of Virginia and same 
antibody purchased from Upstate Biotechnology) or (ii) the 
SP antibody plus a sheep generated anti-ER-13 antiserum 
(1:5000 dilution; code 893/3/34; 41/P3; gift of Dr. Phillipa 
T.K. Saunders, MRC Human Reproductive Sciences, Edin- 
burgh, UK). Sections were washed in phosphate buffered 
saline (PBS), incubated in a mixture of appropriate sec- 
ondary antibodies: donkey anti-guinea pig IgG labeled with 
CY-3 (1:800 dilution) (Jackson Immunoresearch) + donkey 
anti-rabbit IgG labeled with Alexa 488 (Molecular Probes) 
or donkey anti-guinea pig IgG labeled with CY-3 (Jackson 
 
 
Immunoresearch) + donkey anti-sheep IgG labeled with 
Alexa 488 (1:100 dilution) (Molecular Probes) for 1 h and 
mounted in PBS:glycerol. 
The SP antibody is well characterized [59]. The ER-G 
antiserum coded C1355 was raised against the last 14 
amino acids of the ER and its characterization is established 
[24]. The ER-13 antiserum was raised in sheep against the 
N-terminal (code 893/3/34 and 41/P3) and the hinge (code 
913/l/36/P4) regions of the ER protein [75]. Controls in- 
cluded omission of the primary antiserum, omission of the 
secondary antibody, absorption of the primary antiserum 
with its respective antigen (10 µg/ml of diluted antiserum), 
and cross-absorption controls. 
Tissue sections were viewed with an Olympus Provis Mi- 
croscope equipped for epifluorescence microscopy (single 
excitation and emission and dual excitation/emission filters 
for Alexa488/FITC and CY-3/TRITC). Images were cap- 
tured with a SPOTTM Digital Camera (Diagnostics Instru- 
ments, Sterling Heights, MI), imported into PhotoShopTM 
V 5.5 (Adobe Systems Inc., San Jose, CA), contrast and 
brightness adjusted if necessary, labeled and then printed. 
In sections immunostained for ER-G+ SP and ER-13 + SP 
neuron somal profiles were estimated (percentage) to present 
an idea of relative frequency of subpopulations expressing 
subtypes of ER and the neuropeptide. Nonadjacent, double- 
stained sections of L6 and S1 DRG from each of three rats 
(n = 3) were mounted on separate slides. From each rat 
nine randomly chosen fields were photographed using a 
20× objective and then printed. The number of ER-positive, 
SP-positive, ER + SP-positive and negative somal profiles 
in each field were counted from prints and the percentage 
and standard error were calculated. Only somal profiles 
with a distinct ER-labeled nucleus or distinct SP-labeled 
cytoplasm were counted as positive and only profiles with a 
distinctively unlabeled nucleus or cytoplasm were counted 
as negative. Profiles in which neither a distinctly labeled 
nor unlabeled nucleus could be identified, i.e. a profile 
sectioned through cytoplasm, were omitted from counts. 
 
2.4. In situ hybridization (ISH) 
 
In situ hybridization was employed to identify the neu- 
rons synthesizing 13-PPT mRNA (and therefore expressing 
SP) in the L6-S1 DRG during pregnancy and at postpartum. 
Pregnant animals were euthanized with sodium pentobarbi- 
tal (100 mg/kg body weight, i.p.) and perfused intra-cardially 
only with 0.9% sodium chloride. The L6-S1 DRG were then 
carefully removed and stored frozen at −80 ◦C until pro- 
cessing. 
 
2.4.1. Preparation of probes 
ISH used specific riboprobes. The 13-PPT mRNA plasmid 
constructs were generated and kindly supplied by Dr. James 
E. Krause (Neurogen Corp., Bradford, CT). cDNA fragment 
of 13-PPT was cloned into the multiple cloning site of pG1 
(Stratagene# 212205) using restriction enzymes. 
The plasmid was linearized with EcoRI and BamHI re- 
striction enzymes, which cut specifically in the polylinker 
region at the opposite end of the insert from the RNA poly- 
merase promotor that transcribes the cRNA. It was then 
purified, washed, and concentrated at 200 ng/ml in 1 × TE. 
Antisense and sense cRNA probes were synthesized using 
35S-UTP (New England Nuclear), purified over a nick col- 
umn (Pharmacia Biotech, USA) and evaluated on a Bio-Rad 
5%-urea ready gel to confirm size of probe and length. 
Only probes showing a single band in each lane were used 
for the experiment. Those showing a ladder pattern in each 
lane were discarded. 
 
2.4.2. Tissue processing and hybridization 
Cryostat sections mounted on slides were fixed in 4% 
para-formaldehyde (pH 9.0), acetylated with 0.25% acetic 
anhydride in 0.1 triethanolamine (TEA; pH 8.0), washed 
in 2 × SSC, dehydrated in ethanol series and air-dried be- 
fore hybridization. Hybridization was performed at 55 ◦C 
for 15–18 h. The slides were then washed in the follow- 
ing post-hybridization buffers: thrice 2 × SSC (with DTT), 
treated with RNase A, washed in 1 × SSC at room tem- 
perature (RT), washed thrice in 0.1 × SSC between 63 
and  67 ◦C  and  dehydrated  in  ethanol  series.  The  slides 
were then air-dried and apposed to hyperfilm-13 max, prior 
to dipping them in Kodak  NTB2 nuclear emulsion and 
exposure. 
 
2.5. Estrogen treatment 
 
In order to determine whether estrogen regulates SP syn- 
thesis via the classical ER pathway nonpregnant rats were 
ovariectomized as described above. After 2 weeks, the rats 
were treated with either increasing doses of 1713-estradiol 
(Sigma Chemical Co.) (0.03, 0.3, 3.0, 30.0 µg per rat daily 
for 4 days, s.c., sacrificed 12 h after last injection) or ER 
antagonist ICI 182 780 (AstraZeneca, Cheshire, UK) (s.c., 
4 mg/kg once 12 h prior to 0.3 µg 1713-estradiol, sacri- ficed 
12 h later) dissolved in 100 µl of sesame oil. Other 
ovariectomized animals were treated only with vehicle (100 
µl). 
 
2.6. Total RNA isolation 
 
Animals (pregnant and ovariectomized rats) were eutha- 
nized with sodium pentobarbital (100 mg/kg body weight), 
IP, and perfused only with 0.9% sodium chloride. The L6-S1 
DRG were then carefully removed and stored in the −80 ◦C 
freezer until processing. Total RNA was isolated from L6-S1 
DRG of individual animals using RNeasy Mini Kit (Qia- 
gen, Valencia, CA). The amount and purity of total RNA for 
each sample were estimated by spectrophotometric analy- 
sis at A260 and A280. The quality of RNA was determined 
by agarose gel electrophoresis following ethidium bromide 
staining. Aliquots of total RNA were diluted in diethylpy- 
rocarbonated (DEPC)-treated water and stored at −80 ◦C. 
 
 
2.7. Semi-quantitative reverse transcription–polymerase 
chain reaction (RT–PCR) 
 
Total RNA from DRG and spinal cord was reverse 
transcribed and amplified in an eppendorf Master Cycler, 
using reagents from Gene AMP Gold RNA PCR Kit (P.E. 
Biosystems, Foster City, CA), according to manufacturer’s 
instructions. Briefly, 0.5–1 µg total RNA was reverse tran- 
scribed and amplified in a 50 µl reaction mixture contain- 
ing the following: 5× RT–PCR buffer, 1.75 mM MgCl2, 
1.2 mM  dNTP’s,  10 U  RNase  inhibitor,  5.0 mM  DTT, 
1 µM random hexamer, 200 nM SP, ER-G or ER-13 (for- 
pliTaq Gold DNA polymerase, 30 U MultiScribe reverse 
tocol used for SP (modification of [41]) was as follows: 
pre-heated for 10 min at 94 ◦C followed by 1 min at 94 ◦C, 
1 min at 60 ◦C, 2 min at 72 ◦C for 29 cycles and finally 
10 min at 72 ◦C. The RT–PCR protocol  used  for  ER-G and 
-13 has been described earlier [82]. The sequences used 
for SP, ER-G and ER-13 were as follows: (i) SP— 
forward: 51-ATG-AAA-ATC-CTC-GTG-GCG-GT-31 , re- 
verse:   51-CAG-CAT-CCC-GTT-TGC-CCA-TT-31   (217-bp 
fragment); (ii) ER-G—forward: 51-TCC-TTC-TAG-ACC- 
CTT-CAG-TGA-AGC-C-31, reverse: 51-ACA-TGT-CAA- 
AGA-TCT-CCA-CCA-TGC-C-31 (287-bp fragment); (iii) 
ER-13—forward: 51-CTC-GGG-GTC-TGA-GTG-CAG-CT- 
C-AAC-31,   reverse:   51-CCG-AGA-GCC-TTC-AAG-GCT- 
ATA-CAA-G-31 (285-bp fragment). 
The RT–PCR reactions were normalized across runs using  
18S ribosomal RNA as a standard. A Quantum RNA Kit 
with 18S primers and competimers for quantitative RT–PCR 
was used (Ambion, Austin, TX). The ribosomal primers for 
this kit yielded a 488-bp PCR fragment. The PCR product 
was separated using agarose gel electrophoresis, visualized 
after staining with SYBR Green 1 and scanned using the 
Kodak 1D Image Station (Rochester, NY). 
 
2.8. Statistical analysis 
 
RIA and RT–PCR data are shown as means and S.D. 
(Figs. 1 and 4). Comparisons among groups were made by 
ANOVA and t-test. P values less than 0.05 were considered 
significant. 
 
 
3. Results 
 
3.1. Radioimmunoassay 
 
3.1.1. SP levels change in the cervix, DRG and spinal cord 
over the course of pregnancy 
RIA analysis revealed increasing SP concentrations in the 
L6-S1 DRG and spinal cord segments over pregnancy with 
a peak at about Day 20 of gestation and nearly a three-fold 
increase in SP concentration between Days 10 and 20 of 
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Fig. 1. Substance P (SP) concentration in the L6-S1 DRG (A), L6-S1 
spinal cord (B) and uterine cervix (C) of pregnant and postpartum rats as 
revealed by radioimmunoassay (RIA). In the DRG (A) and spinal cord 
(B), SP concentration increases during pregnancy with a peak at about 
Day 20, and then decreases thereafter. In the cervix (C), SP concentration 
shows a decrease over pregnancy with a slight increase at about Days 
15–20, but increases at parturition. Values are the mean and SE of SP 
concentration (n = 5). DRG: ∗∗P < 0.0072, ∗P < 0.0671, compared to 
Day 10; spinal cord: ∗P < 0.0001, ∗∗P < 0.0001, compared to Day 10; 
cervix, ∗P < 0.0091, ∗∗P < 0.01, compared to Day 10, (Dunnet’s t-test). 
 
 
 
pregnancy (P < 0.0072) (Fig. 1A and B). The SP concen- 
tration in the cervix showed a trend of decreasing between 
Days 10 and 15 of pregnancy and then a rise thereafter over 
the last trimester of pregnancy when it returns to Day 10 
levels (Fig. 1C). 
 
3.2. Immunohistochemistry 
 
3.2.1. Sensory neurons of DRG coexpress SP and ERs 
Sections of L6-S1 DRG immunostained for ER-G or ER-
13 indicate a subpopulation of neurons immunoreactive for 
each receptor subtype as well as both ERs (see [62]). The 
focus of this study is on neurons that express ER as 
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well as SP immunoreactivity. Sections double immunos- 
tained with a cocktail of antibodies against ER-G + SP and 
ER-13 + SP revealed subpopulations of neurons immunore- 
active for ER-G, ER-13, SP, ER-G + SP, and ER-13 + SP 
(Fig. 2). About 6.4% of somal profiles estimated were im- 
munoreactive for both ER-G + SP and about 15.1% for 
ER-13+SP. Though triple immunostaining ganglion sections 
was not attempted, one should consider, based on previous 
 
 
 
 
Fig. 2. Cryostat sections of the L6-S1 dorsal root ganglia (DRG) from ovariectomized rats double immunostained for ER-G + SP (A, B) and ER-13 + SP 
(C, D). Low magnification view (A) and higher magnification view (B) of the DRG. The nuclei of some DRG neurons are stained only for ER-G (green 
arrows, green nuclei in A, B) and some for ER-13 (green arrows, green nuclei in C, D). Other DRG somata express only SP immunoreactivity (red 
arrows and red cytoplasm in A–D). Some neurons are double stained for ER-G + SP (white arrows, green nuclei + red cytoplasm in A, B) and some 
are double stained for ER-13 + SP (white arrows, green nuclei + red cytoplasm in C, D). White arrowheads in A–D indicate neurons that do not express 
SP nor ER. Double arrowheads in B indicate SP-immunoreactive processes coursing in the ganglia. A specific geographical concentration of subtypes 
of neurons within the DRG was not evident. Scale bar = 25 µm for all figures. 
 
 
 
 
Fig. 3. In situ hybridization analysis showing expression of SP gene as 13-PPT mRNA hybridization signal (silver grains) in neurons of rat L6-S1 
DRG at representative time points during pregnancy (Day 20: A, B, C) and at 2-day postpartum (D). Distinct signals (silver grains) localize largely to 
small (arrowhead) neurons in pregnancy and 2-day postpartum (A, C, D). Overall, the signal intensity in Day 20 pregnant animals was greater than in 
2-day postpartum rats (comparable areas shown in C and D). B is a control section hybridized with the sense probe and shows lack of labeling. Scale 
bar = 20 µm for all figures. 
 
data [62] that some neurons may express both ER-G + 
ER-13 + SP. 
3.3. In situ hybridization 
 
3.3.1. Sensory neurons of DRG express β-PPT mRNA and 
synthesize SP 
In order to confirm a subpopulation of neurons synthesiz- 
ing and expressing SP in the L6-S1 DRG during pregnancy 
and at postpartum, ISH for 13-PPT mRNA was performed. 
13-PPT mRNA signals were localized in small and medium 
size neurons of L6-S1 DRG throughout the stages of preg- 
nancy examined (Days 10, 15, 20, parturition) and 2-day 
postpartum (Fig. 3). 
 
3.4. RT–PCR 
 
3.4.1. SP mRNA in L6-S1 DRG is up-regulated over 
Days 10, 15, 20, parturient (Day 22) of pregnancy and 
down-regulated by 2-day postpartum 
SP mRNA bands showed a noticeable density increase 
over pregnancy and an apparent decrease by 2-days post- 
partum (Fig. 4A). This change became more apparent when 
the bands were scanned using the Kodak 1D Image Sta- 
tion to produce a histogram of the net intensity of the bands 
(Fig. 4A, right). The difference in net intensity of bands at 
parturient (Day 22) versus Day 10 was statistically signifi- 
cant (P < 0.05). 
 
3.4.2. Exogenous estrogen up-regulates SP mRNA in L6-S1 
DRG and this effect can be blocked by ER antagonist ICI 
182 780 
Ovariectomized rats treated with increasing doses of 
1713-estradiol (0.03, 0.3, 3, and 30 µg per rat per day for 4 
days) showed a dose-related increase of SP mRNA synthe- 
sis in L6-S1 DRG between the ranges of 0.03–3.0 µg (no 
further response was observed beyond 3.0 µg) (Fig. 4B). 
There was a statistical difference between dosages 0.03 and 
0.3 µg, and between 0.03 and 3 µg (P < 0.05). 
Since exogenous estrogen up-regulates SP mRNA ex- 
pression and both ER-G and -13 are expressed in neurons 
of these ganglia [62,82], we examined whether the estro- 
gen effects on SP mRNA synthesis were ER-mediated. 
Administration of the ER antagonist ICI 182 780 to 
ovariectomized rats 12 h prior to 1713-estradiol, reduces 
the effects of estrogen (at 3.0 µg) on SP mRNA ex- 
pression (Fig. 4C). The partial blockage of SP mRNA 
synthesis  by  ER  blocker  ICI  182  780  was  statistically 
 
 
 
 
Fig. 4. Data from RT–PCR analysis showing changes in SP, ER-G and ER-13 mRNAs in L6-S1 DRG at representative time points during pregnancy, the 
effect of estrogen treatment, and the effect of an estrogen receptor blocker. SP (A), ER-G (D) and ER-13 (E) mRNAs in the DRG of rats at pregnant days 10, 
15, 20, parturient (Day 22) and 2-days postpartum. (B) Effect of short-term estrogen treatment, of various doses, on SP mRNA in DRG in ovariectomized 
rats. (C) Outcome of pretreatment with the estrogen receptor blocker (ICI 182 780) on the short-term treatment effects of estrogen on SP mRNA in DRG 
of ovariectomized rats. 18S mRNA was used as an internal control. Scanned images of SYB green-stained gels on the left (i) and intensity plotted as a 
histogram on the right (ii). (A) SP mRNA shows a trend toward up-regulation during pregnancy and decreasing after birth, (B) estrogen administration to 
ovariectomized rats up-regulates SP mRNA in a dose-related manner with a maximum effect at 3.0 µg, (C) prior administration of ER blocker ICI 182 
780 partially prevented the estrogen-induced up-regulation of SP mRNA, (D) ER-G mRNA was up-regulated over pregnancy and decreased after birth, 
whereas ER-13 mRNA levels (E) remained relatively stable. Note the scale differences for the histograms for ER-G vs. ER-13 mRNA. E: estrogen treatment, 
ICI + E: estrogen blocker ICI 182 780 + estrogen treatment. (A) ∗P < 0.05, compared to Day 10; (B) ∗∗P < 0.001, ∗P < 0.05, compared to 0.03 µg 
estrogen dosage; (C) ∗P < 0.01, compared to estrogen treatment; (D) ∗P < 0.023, compared to Day 10; (E) all days not statistically different; (t-test). 
 
 
significant compared to the 1713-estradiol-treated animals 
(P < 0.05). 
Because ICI 182 780 blocks both subtypes of ER, namely 
ER-G and -13, we examined whether the expression of both 
subtypes are in L6-S1 DRG for a clue as to the subtype likely 
to mediate SP mRNA expression in pregnancy. RT–PCR data 
revealed that ER-G mRNA tended to increase over pregnancy 
with a peak at Day 20 of pregnancy (Fig. 4D). In contrast, 
ER-13 mRNA levels generally remained stable across preg- 
nancy and were basically unchanged from those expressed 
in the nonpregnant rat (Fig. 4E). The difference between 
Day 20 and Day 10 was statistically significant for ER-G 
mRNA (P < 0.023), whereas no significant difference was 
seen between any representative time points in the case of 
ER-13 mRNA. 
 
 
4. Discussion 
 
The important findings of this study are that (1) concentra- 
tion of SP in L6-S1 DRG rises over the last trimester of preg- 
nancy, but is lower in the cervix during the same period, (2) 
DRG neurons coexpress ER and SP, (3) SP mRNA in DRG 
increases over pregnancy and responds in a dose-related 
manner to estrogen, and (4) ER blocker ICI 182 780 atten- 
uates this estrogen effect. These data suggest that estrogen 
has a role in up-regulation of SP mRNA and SP synthesis, in 
part via the ER signaling pathway. These findings are novel 
in that they strongly implicate interactions between estro- 
gen and the neuropeptide SP in the somata of DRG neurons, 
their central processes in the spinal cord and peripheral ter- 
minals in the uterine cervix. 
Moreover, the fundamental components of neurogenic in- 
flammation important for cervical ripening in the cervix of 
late-pregnant rats, i.e. a network of nerves immunoreactive 
for inflammation-associated neuropeptides and presence of 
their receptors closely associated with cervical venules dur- 
ing pregnancy, was established by a previous study [16]. 
The present findings support the data suggesting that SP is 
important in changes occurring at cervical ripening and par- 
turition. 
Various substances have been studied extensively for their 
involvement in parturition including cytokines (IL-1, -6, -8 
and TNF), oxytocin, prostaglandins and steroid hormones 
[1,51,83]. Interestingly, disruption of individual genes for 
these substances fails to stop reproductive processes in mice 
[34] suggesting there is a multiplicity of factors at play in 
cervical ripening and parturition and possibly some, as yet, 
undiscovered factors. Along this line, Carlson and De Feo 
[11], Higuchi et al. [27] and Burden et al. [10] reported that 
severing the pelvic nerves enroute to the cervix interferes 
with, or blocks parturition. This prompted research on fac- 
tors in the pelvic nerves that are crucial to cervical ripening 
and parturition. 
The cervix is innervated largely by pelvic nerves 
[4,5,58,65,66,85] arising from L6-S1 spinal cord segments, 
though there are contributions from the vagus [15,30,36,56] 
and hypogastric nerves [5,17,66]. Sensory fibers of the 
pelvic nerve are most vital for parturition as bilateral dorsal 
rhizotomy at Days 8–10 of pregnancy produces dystocia 
whereas bilateral transection of ventral roots does not [10]. 
Moreover, transection of pelvic and hypogastric nerves 
blocks reflexive postpartum ovulation that is stimulated by 
passage of the fetuses through the cervix [17]. The DRG 
is the major, if not exclusive, source of SP in the cervix 
[57,58,85] and SP is present in small capsaicin-sensitive 
sensory neurons [69,85]. Afferent nerves that release trans- 
mitters from their central terminals in the spinal cord also 
perform an efferent  function by releasing  neuropeptides 
from their terminals in target tissue [29,48,52]. SP, when 
released from the sensory nerves, produces several effects 
in peripheral organs [29,31,48] including vasodilation, in- 
creased permeability of postcapillary venules with plasma 
extravasation, and recruitment and activation of inflamma- 
tory immune cells. These effects are essential features of 
neurogenic inflammation and are involved in tissue rear- 
rangements [7,21,31,52,73,81]. Tissue rearrangements of 
cervical ripening in preparation for parturition begin at about 
Day 20 in the rat [16,18] and resemble those described for 
neurogenic inflammation [16]. Thus, our data showing in- 
creased synthesis of SP in the DRG over pregnancy, with a 
peak at about Day 20, taken in conjunction with decreasing 
levels in the cervix, possibly indicating increased release 
and utilization, support the hypothesis that SP and a local 
neurogenic inflammatory-type reaction are important com- 
ponents of cervical ripening [16,42]. It could be argued that 
increased SP in the DRG with decreased SP in the cervix 
may result from increased storage versus release. However, 
the fact that the SP receptor NK1, which is important in 
pain and inflammatory conditions [68], is up-regulated in 
the pregnant cervix maximally at Days 20–22 [16] is more 
consistent with the postulated increased release of SP in 
the cervix at this time, than increased storage. This data 
parallels that of estrogen effects on SP-receptor mRNA 
levels and SP binding in an in vivo and model cell system 
[9,22,89]. Moreover, the slight rise in SP concentration in 
the cervix of parturient animals may result from the maxi- 
mized egress of immune cells from the vasculature at this 
stage, many of which synthesize SP [38]. 
In situ hybridization data revealed most intense 13-PPT 
signal in small neurons with light to moderate signal in 
medium-size neurons. This may explain why selective an- 
tidromic stimulation of C-type axons of (from small DRG 
neurons) and A-delta (from medium-size neurons) (which 
induce local neuropeptide release, including SP) have differ- 
ential effects on pelvic organs. Stimulation of C-fibers (with 
a higher SP content) causes both vasodilation and neuro- 
genic inflammation, whereas, stimulation at frequencies for 
A-delta fibers causes only vasodilation [66]. We infer that, 
based on the collective data above, cervical ripening involves 
a neurogenic inflammatory-type reaction as an orderly and 
timely component of cervix remodeling which is vital for 
 
 
passage of the fetus at parturition. In addition, increased SP 
synthesis in the DRG and transport to, and release in, the 
cervix at late pregnancy is an important part of this process 
in the rat. Though SP concentration is lower in the cervix 
over the last trimester of pregnancy, there was increased 
concentration of SP in the DRG and dorsal one-half of the 
spinal cord. The increased concentration of SP in the spinal 
cord is intriguing, but if it reflects peptide synthesized and 
transported from the DRG neurons, peptide intrinsic to the 
spinal cord, SP derived from supraspinal sources or a com- 
bination of these is presently unknown. Dorsal rhizotomy 
and capsaicin-treatment, showed that significant SP content 
of the L6 spinal dorsal horn is from CNS source(s), though 
the intrinsic sources were not identified [86]. 
Estrogen and progesterone play key roles in establish- 
ing the environment leading to successful pregnancy and 
full-term labor [8,14,78,87]. During the period of proges- 
terone dominance in early pregnancy the cervix is firm and 
tightly closed. At late pregnancy a sharp rise in estrogen 
levels changes the estrogen: progesterone balance which fa- 
vors cervical ripening [78]. This change in hormonal mi- 
lieu up-regulates factors that enhance uterine contraction and 
cervical ripening, e.g. oxytocin receptor [25,26,39,88] and 
immune cells [16,47]. Moreover, coexistence of ER and SP 
in sensory neurons of lumbosacral DRG neurons implicates 
estrogen in the regulation of SP expression and SP involve- 
ment in cervical ripening. Furthermore, the temporal coinci- 
dence in the rat (at about Day 20) in the rise of serum estro- 
gen (and decline of progesterone) [8,46,76], up-regulation 
of ER-G mRNA, SP mRNA, and SP in L6-S1 DRG (present 
study), strongly supports the notion that estrogen, working 
through ERs, positively influences SP expression. 
L6-S1 DRG neurons project axons to pelvic organs other 
than the uterus and cervix, e.g. the urinary bladder 
[19,20,33,80] and some of these neurons express ERs [3]. 
Thus, estrogen could influence the function of the urinary 
system in addition to the reproductive tract [2,6,32,84]. This 
influence could occur at the level of the epithelium, smooth 
muscle, or nerves [3,23,50]. Consequently, it is likely that 
all ER-positive neurons examined in the present study were 
not necessarily uterus-related. Though, it should be noted 
that previous studies have not reported a direct effect of 
steroid hormones on bladder responses to nerve stimulation 
[74] and micturition thresholds were not altered by estrous 
cycle stage (i.e. circulating hormone level) in normal rats 
(but only in bladder inflamed rats) [32]. In any case, this in- 
formation calls forth an important point, i.e. caution should 
be exercised when making interpretations about neurons 
expressing ERs and their role(s) only in reproductive organ 
circuitries. 
Estrogen effects are mediated largely by ER-G and -13 
[35,37]. Small- and medium-size sensory neurons in L6-S1 
DRG express one or both ER isoforms [3,62,64]. The present 
study revealed that ER-G mRNA is up-regulated during 
pregnancy, whereas, ER-13 remains largely unchanged im- 
plying that ER-G may play a dominant role during preg- 
nancy and, possibly mediate up-regulation of SP synthesis. 
1713-Estradiol stimulated SP mRNA synthesis in ovariec- 
tomized rats, an effect blocked by pretreatment with an ER 
antagonist suggesting that SP synthesis in the DRG during 
pregnancy may be regulated by the estrogen–ER signaling 
pathway. Because we do not know if the 13-PPT gene has 
an estrogen-responsive element (ERE) [54], it is not clear 
precisely how estrogen regulates SP. A proposal is that es- 
trogen regulates SP synthesis indirectly by modulating NGF 
or trkA [43,77], which express EREs, and these regulate SP 
[43–45]. ICI 182 780, may, therefore, block SP up-regulation 
by preventing binding of the estrogen–ER complex to the 
ERE of NGF. 
Taking the present data in concert with the current lit- 
erature we propose one avenue by which estrogen may 
influence initiation of cervical ripening. Estrogen could en- 
hance the sensitivity of nerves at the internal of the cervix 
to fetal mechanical stimuli and up-regulate synthesis of SP 
and NK1 in DRG and cervix, respectively with concomi- 
tant enhanced release of SP in the cervix. SP, in concert 
with other inflammation-associated neuropeptides, pro- 
motes a neurogenic inflammatory-type response and tissue 
rearrangements. Thus, SP, in part, under the influence of 
estrogen–ER-G, may help establish conditions critical for 
cervical ripening in preparation for parturition. 
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